MELD vs Child-Pugh and creatinine-modified Child-Pugh score for predicting survival in patients with decompensated

Related Experiment Videos

George V Papatheodoridis1, Evangelos Cholongitas, Eleni Dimitriadou

  • 12nd Department of Internal Medicine, National University of Medical School, Hippokration General Hospital, 114 Vas. Sophias Ave., 115 27 Athens, Greece. gpapath@cc.uoa.gr

Abstract

Insights

The Model of End-stage Liver Disease (MELD) score and creatinine-modified Child-Pugh scores show similar predictive value for decompensated cirrhosis survival. Neither MELD nor modified Child-Pugh offers a clear advantage over the other in clinical practice.

Area of Science:

  • Hepatology
  • Clinical Prognostics
  • Medical Statistics

Background:

  • Decompensated cirrhosis requires accurate survival prediction.
  • The Model of End-stage Liver Disease (MELD) score is increasingly used, replacing the Child-Pugh score.
  • The utility of creatinine-modified Child-Pugh scores remains under investigation.

Purpose of the Study:

  • To compare the predictive accuracy of MELD, Child-Pugh, and creatinine-modified Child-Pugh scores.
  • To evaluate these scores in predicting survival in patients with decompensated cirrhosis.

Main Methods:

  • A cohort of 102 patients with decompensated cirrhosis was studied.
  • Creatinine levels were incorporated into the Child-Pugh score to create modified versions.
  • Receiver operating characteristic curves and Cox regression analysis were used for comparison.

Main Results:

  • No significant difference in diagnostic accuracy was found among the four scoring systems (AUC: 0.71-0.79).
  • MELD and creatinine-modified Child-Pugh scores demonstrated comparable or slightly better predictive values than the original Child-Pugh score.
  • Adjusting for gamma-glutamate transpeptidase improved the predictive value of all systems.

Conclusions:

  • The MELD score does not offer a clear advantage over creatinine-modified Child-Pugh scores for predicting survival in decompensated cirrhosis.
  • Current scoring systems show moderate predictive accuracy, suggesting room for improvement in clinical practice.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance (Clcr), a...
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...